Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO-203 in Healthy Volunteers and Systemic Sclerosis
NCT07641634Phase 2Recruiting
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Countries
- 4
01
Overview
A Phase 2 trial of CM355 in systemic sclerosis (SSc). Started Oct 2025; status: recruiting.
02
Drugs
CM355
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT07641634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07641634.